Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Effects of Minocycline as a Neuroprotective Agent for Stroke on Mmp-9 Levels, Functional Outcome, and Mortality

Folia Medica Indonesiana · Vol. 60 No. 2 (2024) · hlm. 167–181

DOI
10.20473/fmi.v60i2.58931
ISSN
2355-8393, 2599-056X
Terbit
2024-06-10
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Highlights:1. As minocycline plays an important role in stroke microglia activation and iron chelation, it is important to further analyze its effects on stroke treatment.2. This meta-analysis revealed a significant effect of minocycline therapy, as evidenced by improved functional outcomes and inhibited matrix metalloproteinase-9 (MMP-9) activity. Abstract Stroke is the most common and devastating cerebrovascular disease. Many neuroprotective medications, such as scale and minocycline, have been developed to help the nervous system recover or regenerate after a stroke. However, it remains unclear whether minocycline provides a beneficial effect on stroke. We conducted this systematic review and meta-analysis to synthesize the effects of minocycline in stroke treatment. The systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO), with registration number CRD42023485168. The quality of the eligible studies was assessed using the Jadad scale. This systematic review included three ischemic stroke trials, seven intracerebral hemorrhage trials, and one study on acute stroke. There was a significant association between minocycline intervention and stroke severity according to the National Institute of Health Stroke Scale (NIHSS), with a pooled mean difference (MD) of -1.92, a 95% confidence interval (CI) of -3.39 to -0.45, and a value of p=0.01. In the subgroup of ischemic stroke, the modified Rankin Scale (mRS) was significantly lower in the minocycline treatment group compared to the control group (MD=-0.89, 95% CI=-1.54 to -0.25, p=0.007). Additionally, matrix metalloproteinase-9 (MMP-9) levels for the intracerebral hemorrhage subgroup were significantly lower in the minocycline treatment group compared to the control group (MD=-19.93, 95% CI=-36.9 to -2.96, p=0.02). The analysis revealed that minocycline intervention was not significantly associated with hematoma volume, mortality, or stroke recurrence. Our findings indicate that minocycline supplementation is a potential intervention strategy for treating ischemic stroke and intracerebral hemorrhage.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 244 tautan kepenulisan bersama · 31 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Sebelas Maret University
  • Diponegoro University
  • Universitas Airlangga
  • Universitas Binawan
  • Universitas Gadjah Mada
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Raden Andi Ario TedjoSebelas Maret University4
Rivan DanuajiSebelas Maret University3
Stefanus Erdana PutraSebelas Maret University3
Muhammad HafizhanSebelas Maret University3
Ervina Arta Jayanti HutabaratSebelas Maret University3
Yetty HambarsariSebelas Maret University3
Teddy TejomuktiSebelas Maret University3
Suhartini IsmailDiponegoro University2
Diah Kurnia MirawatiSebelas Maret University2
Ira RistinawatiSebelas Maret University2
Hanindia Riani PrabaningtyasSebelas Maret University2
Subandi SubandiSebelas Maret University2
Pepi BudiantoSebelas Maret University2
Widaryati WidaryatiAfiliasi tidak diketahui1
Muhammad Arsyad SubuUniversitas Binawan1
Ani MargawatiDiponegoro University1
Refonda Rias AnggiriDiponegoro University1
Sumardi SumardiUniversitas Gadjah Mada1
Dodik TugasworoDiponegoro University1
Aditya KurniantoDiponegoro University1
Yovita AndhitaraDiponegoro University1
Rahmi ArdhiniDiponegoro University1
Tomy NugrohoDiponegoro University1
Jethro BudimanDiponegoro University1
Lawly Arrel Dionnie GreatalyaAfiliasi tidak diketahui1
Suroto SurotoDiponegoro University1
Vivienne TjungSebelas Maret University1
Suroto SurotoSebelas Maret University1
Kenneth TanSebelas Maret University1
Benedictus BenedictusSebelas Maret University1
Subandi SubandiSebelas Maret University1
Christopher Daniel TristanSebelas Maret University1
Muhammad Farid HamkaSebelas Maret University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Effects of Minocycline as a Neuroprotective Agent for Stroke on Mmp-9 Levels, Functional Outcome, and Mortality</dc:title><dc:creator>Ayu Imamatun Nisa</dc:creator><dc:creator>Arlia Ayu Damayanti</dc:creator><dc:creator>Jeffri Nagasastra</dc:creator><dc:creator>Abdulloh Machin</dc:creator><dc:creator>Mohammad Fathul Qorib</dc:creator><dc:creator>Retnaningsih Retnaningsih</dc:creator><dc:creator>Baarid Luqman Hamidi</dc:creator><dc:subject>minocycline</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>stroke</dc:subject><dc:subject>ischemic stroke</dc:subject><dc:subject>intracerebral hemorrhage</dc:subject><dc:subject>MMP-9</dc:subject><dc:subject>functional outcome</dc:subject><dc:subject>mortality</dc:subject><dc:subject>microglial activation</dc:subject><dc:subject>iron chelation</dc:subject><dc:subject>hematoma volume</dc:subject><dc:subject>stroke recurrence</dc:subject><dc:description xml:lang="en">Highlights:1. As minocycline plays an important role in stroke microglia activation and iron chelation, it is important to further analyze its effects on stroke treatment.2. This meta-analysis revealed a significant effect of minocycline therapy, as evidenced by improved functional outcomes and inhibited matrix metalloproteinase-9 (MMP-9) activity. Abstract Stroke is the most common and devastating cerebrovascular disease. Many neuroprotective medications, such as scale and minocycline, have been developed to help the nervous system recover or regenerate after a stroke. However, it remains unclear whether minocycline provides a beneficial effect on stroke. We conducted this systematic review and meta-analysis to synthesize the effects of minocycline in stroke treatment. The systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO), with registration number CRD42023485168. The quality of the eligible studies was assessed using the Jadad scale. This systematic review included three ischemic stroke trials, seven intracerebral hemorrhage trials, and one study on acute stroke. There was a significant association between minocycline intervention and stroke severity according to the National Institute of Health Stroke Scale (NIHSS), with a pooled mean difference (MD) of -1.92, a 95% confidence interval (CI) of -3.39 to -0.45, and a value of p=0.01. In the subgroup of ischemic stroke, the modified Rankin Scale (mRS) was significantly lower in the minocycline treatment group compared to the control group (MD=-0.89, 95% CI=-1.54 to -0.25, p=0.007). Additionally, matrix metalloproteinase-9 (MMP-9) levels for the intracerebral hemorrhage subgroup were significantly lower in the minocycline treatment group compared to the control group (MD=-19.93, 95% CI=-36.9 to -2.96, p=0.02). The analysis revealed that minocycline intervention was not significantly associated with hematoma volume, mortality, or stroke recurrence. Our findings indicate that minocycline supplementation is a potential intervention strategy for treating ischemic stroke and intracerebral hemorrhage.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2024-06-10</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.20473/fmi.v60i2.58931</dc:identifier><dc:identifier>10.20473/fmi.v60i2.58931</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 60 No 2 (2024); 167-181</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>